I'm reaching out to the scientists and the knowledgable on this board. Subject of recent EUA.
Bamlanivimab: effects on viral load....reduction in both hospitalizations and ER visits and lastly safety.....does not change with the dosing...from a low of 700 milligrams to 7000 milligrams. How effective can it be if dosing has no bearing on the end result?...someone educate me.